Circulating miR-30b levels increase during male puberty.
Adolescent
Drug Therapy, Combination
Gonads
/ drug effects
Growth Disorders
/ blood
Hormone Replacement Therapy
Humans
Hypothalamo-Hypophyseal System
/ drug effects
Injections, Intramuscular
Letrozole
/ administration & dosage
Longitudinal Studies
Male
MicroRNAs
/ blood
Puberty
/ blood
Puberty, Delayed
/ blood
Testosterone
/ administration & dosage
Ubiquitin-Protein Ligases
/ genetics
Journal
European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
12
11
2020
accepted:
05
03
2021
pubmed:
6
3
2021
medline:
29
4
2021
entrez:
5
3
2021
Statut:
ppublish
Résumé
The role of miRNA as endocrine regulators is emerging, and microRNA mir-30b has been reported to repress Mkrn3. However, the expression of miR-30b during male puberty has not been studied. Circulating relative miR-30b expression was assessed in sera of 26 boys with constitutional delay of growth and puberty (CDGP), treated with low-dose testosterone (T) (n =11) or aromatase inhibitor letrozole (Lz) (n =15) for 6 months and followed up to 12 months (NCT01797718). The associations between the relative expression of miR-30b and hormonal markers of puberty were evaluated. During the 12 months of the study, circulating miR-30b expression increased 2.4 ± 2.5 (s.d.) fold (P = 0.008) in all boys, but this change did not correlate with corresponding changes in LH, testosterone, inhibin B, FSH, or testicular volume (P = 0.25-0.96). Lz-induced activation of the hypothalamic-pituitary-gonadal (HPG) axis was associated with more variable miR-30b responses at 3 months (P < 0.05), whereas those treated with T exhibited significant changes in relative miR-30b levels in the course the study (P < 0.01-0.05). Circulating miR-30b expression in boys with CDGP increases in the course of puberty, and appears to be related to the activity of the HPG axis.
Identifiants
pubmed: 33667194
doi: 10.1530/EJE-20-1307
pii: EJE-20-1307
doi:
pii:
Substances chimiques
MIRN30b microRNA, human
0
MicroRNAs
0
Testosterone
3XMK78S47O
Letrozole
7LKK855W8I
MKRN3 protein, human
EC 2.3.2.27
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM